Volume 93, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Samples collected in 2012 through diarrheal disease surveillance in Haiti were tested for rotavirus by enzyme immunoassay and real time RT-PCR and positive samples were genotyped. The predominant genotypes were G1P[8] (29% prevalence) and G9P[8] (21%). The observed genotype prevalence was similar to that reported previously for other Caribbean countries.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI, , 2009. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 200 (Suppl 1): S9S15.[Crossref] [Google Scholar]
  2. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network; , 2012. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 12: 136141.[Crossref] [Google Scholar]
  3. de Oliveira LH, Danovaro-Holliday MC, Sanwogou NJ, Ruiz-Matus C, Tambini G, Andrus JK, , 2011. Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean: four years of accumulated experience. Pediatr Infect Dis J 30 (Suppl): S61S66.[Crossref] [Google Scholar]
  4. WHO, 2008. Estimated Rotavirus Deaths for Children Under 5 Years of Age: 2008. Available at: http://wwwwhoint/immunization/monitoring_surveillance/burden/estimates/rotavirus/en/. [Google Scholar]
  5. WHO, 2009. Rotavirus vaccines: an update. Wkly Epidemiol Rec 84: 533537. [Google Scholar]
  6. Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD, , 2012. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030. Vaccine 30 (Suppl 1): A7A14.[Crossref] [Google Scholar]
  7. Linhares AC, Velazquez FR, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruiz-Palacios GM, De Vos B, O'Ryan M, Gillard P, Bouckenooghe A, Human Rotavirus Vaccine Study Group; , 2008. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 371: 11811189.[Crossref] [Google Scholar]
  8. Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T, , 2007. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Revista Panam Salud Publica 21: 205216.[Crossref] [Google Scholar]
  9. Steenland MW, Joseph GA, Lucien MA, Freeman N, Hast M, Nygren BL, Leshem E, Juin S, Parsons MB, Talkington DF, Mintz ED, Vertefeuille J, Balajee SA, Boncy J, Katz MA, , 2013. Laboratory-confirmed cholera and rotavirus among patients with acute diarrhea in four hospitals in Haiti, 2012–2013. Am J Trop Med Hyg 89: 641646.[Crossref] [Google Scholar]
  10. Mijatovic-Rustempasic S, Tam KI, Kerin TK, Lewis JM, Gautam R, Quaye O, Gentsch JR, Bowen MD, , 2013. Sensitive and specific quantitative detection of rotavirus A by one-step real-time reverse transcription-PCR assay without antecedent double-stranded-RNA denaturation. J Clin Microbiol 51: 30473054.[Crossref] [Google Scholar]
  11. Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, Cortese MM, Parashar UD, Glass RI, Bowen MD, National Rotavirus Strain Surveillance System; , 2011. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 30 (Suppl): S42S47.[Crossref] [Google Scholar]
  12. Levy K, Hubbard AE, Eisenberg JN, , 2009. Seasonality of rotavirus disease in the tropics: a systematic review and meta-analysis. Int J Epidemiol 38: 14871496.[Crossref] [Google Scholar]
  13. Bourdett-Stanziola L, Jimenez C, Ortega-Barria E, , 2008. Diversity of human rotavirus G and P genotypes in Panama, Costa Rica, and the Dominican Republic. Am J Trop Med Hyg 79: 921924. [Google Scholar]
  14. Bourdett-Stanziola L, Ortega-Barria E, Espinoza F, Bucardo F, Jimenez C, Ferrera A, , 2011. Rotavirus genotypes in Costa Rica, Nicaragua, Honduras and the Dominican Republic. Intervirology 54: 4952.[Crossref] [Google Scholar]
  15. de Oliveira LH, Danovaro-Holliday MC, Andrus JK, de Fillipis AM, Gentsch J, Matus CR, Widdowson MA, Rotavirus Surveillance Network; , 2009. Sentinel hospital surveillance for rotavirus in Latin American and Caribbean countries. J Infect Dis 200 (Suppl 1): S131S139.[Crossref] [Google Scholar]
  16. Ribas M de L, Nagashima S, Calzado A, Acosta G, Tejero Y, Cordero Y, Piedra D, Kobayashi N, , 2011. Emergence of G9 as a predominant genotype of human rotaviruses in Cuba. J Med Virol 83: 738744.[Crossref] [Google Scholar]
  17. Banyai K, Laszlo B, Duque J, Steele AD, Nelson EA, Gentsch JR, Parashar UD, , 2012. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 30 (Suppl 1): A122A130.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 30 Jun 2014
  • Accepted : 29 Mar 2015
  • Published online : 08 Jul 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error